Cdi Corp (CDI) 13.73 $CDI Downtrend Call Working As CDI

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cdi Corp (CDI) 13.73 $CDI

Downtrend Call Working As CDI Stock Falls 16.9% (CDI)
Comtex SmarTrend(R) - Thu Mar 19, 9:38AM CDT
SmarTrend identified a Downtrend for CDI (NYSE:CDI) on March 4th, 2015 at $16.31. In approximately 2 weeks, CDI has returned 16.92% as of today's recent price of $13.55.
CDI: 13.73 (+0.38)

RSI Alert: CDI Corp. Now Oversold
DividendChannel.com - Wed Mar 04, 2:59PM CST
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a...
CDI: 13.73 (+0.38)

CDI Corp's (CDI) CEO Scott Freidheim on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 04, 12:27PM CST

CDI: 13.73 (+0.38)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 11:45AM CST

BV: 5.90 (+0.01), SPPR: 1.67 (-0.01), XPLR: 6.05 (+0.05), PHMD: 1.79 (+0.04), BOBE: 46.64 (+0.28), NVGN: 3.82 (-0.14), PDII: 1.55 (+0.02), EFUT: 3.98 (-0.08), CECO: 5.59 (-0.25), CENX: 14.04 (-0.11), VEEV: 27.28 (-0.65), CDI: 13.73 (+0.38), CYCC: 0.98 (+0.02), FSTR: 45.55 (+0.05), ANF: 21.87 (+0.53), CNDO: 3.90 (-0.31), NPTN: 6.29 (+0.03), PTN: 1.02 (-0.02), CAPN: 5.37 (-0.33), IFON: 2.30 (+0.03)

CDI misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 5:33PM CST

CDI: 13.73 (+0.38)

CDI announces Q1 2015 dividend of USD0.13 per share
M2 - Tue Mar 03, 4:55AM CST
The board of directors of CDI Corp (NYSE:CDI), a provider of client-focused engineering, information technology and staffing solutions, approved a first quarter 2015 dividend of USD0.13 per share, the company revealed on Monday.
CDI: 13.73 (+0.38)

CDI declares $0.13 dividend
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 4:18PM CST

CDI: 13.73 (+0.38)

CDI Corp. Declares First Quarter 2015 Dividend
PR Newswire - Mon Mar 02, 4:16PM CST
CDI Corp. (NYSE: CDI) today announced that its Board of Directors has authorized a first quarter 2015 dividend of $0.13 per share. The dividend is payable on March 30, 2015, to holders of record as of the close of business on March 16, 2015.
CDI: 13.73 (+0.38)

CDI Shares Up 13.1% Since SmarTrend's Buy Recommendation (CDI)
Comtex SmarTrend(R) - Wed Feb 18, 10:03AM CST
SmarTrend identified an Uptrend for CDI (NYSE:CDI) on October 28th, 2014 at $16.30. In approximately 4 months, CDI has returned 13.13% as of today's recent price of $18.44.
CDI: 13.73 (+0.38)

Uptrend Call Working As CDI Stock Rises 13.9% (CDI)
Comtex SmarTrend(R) - Tue Feb 10, 9:13AM CST
SmarTrend identified an Uptrend for CDI (NYSE:CDI) on October 28th, 2014 at $16.30. In approximately 4 months, CDI has returned 13.93% as of today's recent price of $18.57.
CDI: 13.73 (+0.38)

CDI Corp. To Hold Fourth Quarter 2014 and Full Year 2014 Earnings Conference Call on March 4
PR Newswire - Tue Feb 03, 4:00PM CST
CDI Corp. (NYSE: CDI) will hold a conference call to review results for its fourth quarter and full year ended December 31, 2014. The public is invited to listen to the conference call on Wednesday, March 4, 2015, at 8:30 am Eastern time. Financial results will be released following the market close on March 3, 2015.
CDI: 13.73 (+0.38)

CDI Corp. Names Michael S. Castleman Chief Financial Officer
PR Newswire - Mon Jan 26, 3:30PM CST
CDI Corp. (NYSE: CDI) (the "Company" today announced that Michael S. Castleman has assumed day-to-day responsibilities for financial operations and management and, subsequently, will assume the role of Chief Financial Officer following the filing of the Company's SEC Form 10-K for 2014 in early March 2015. He will continue to lead corporate development and operational analytics at CDI.
CDI: 13.73 (+0.38)

NYSE stocks posting largest volume increases
AP - Thu Jan 08, 5:10PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
PMC: 27.65 (-0.20), FRO: 2.40 (-0.14), CDI: 13.73 (+0.38), CYNI: 4.10 (+0.14), DHT: 6.89 (-0.02), DKS: 58.46 (+1.11), CDR: 7.61 (+0.10), RPM: 48.41 (+0.32), CRD.B: 8.75 (+0.04), CRD.A: 7.40 (-0.26), TNK: 5.45 (-0.33)

The Best Small-Cap Dividend Growers: Resources Connection
Stan Stafford - at Seeking Alpha - Fri Dec 12, 1:21PM CST

CDI: 13.73 (+0.38), HSII: 24.32 (-0.02), RECN: 17.31 (+0.01), KELYA: 17.59 (-0.11)

CDI (CDI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 29, 7:25AM CDT

CDI: 13.73 (+0.38)

CDI beats by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 10:37PM CDT

CDI: 13.73 (+0.38)

CDI Corp. Strengthens Executive Team with Three Corporate Veterans
PR Newswire - Tue Oct 28, 7:00PM CDT
CDI Corp. (NYSE: CDI) (the "Company" today announced that it has added three corporate leaders to its executive management team. David Arkless will serve as President, International; Michael Castleman will be Executive Vice President, Corporate Development and Operations; and Hugo Malan will join as Executive Vice President, President of Staffing for North America. Together, these hires signify a focused effort by the company to build an executive team that will accelerate value creation for shareholders.
CDI: 13.73 (+0.38)

CDI Corp. Reports Third Quarter 2014 Results
PR Newswire - Tue Oct 28, 6:00PM CDT
CDI Corp. (NYSE: CDI) (the "Company" today reported results for the third quarter ended September 30, 2014.
CDI: 13.73 (+0.38)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LONGi's Four Paths to Global Green Development

Updated Category News Views 62

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 149

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 469

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 92

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

AAVantgarde's Professor Auricchio Receives Prestigious Role

Updated Category News Views 177

AAVantgarde's Professor Auricchio Achieves New Milestone MILAN, a milestone moment has arrived for AAVantgarde Bio as Professor Alberto Auricchio, the visionary Founder and Chief Scientific Officer, has been elected President of the European Society of Gene and Cell Therapy. This prestigious appointment recognizes his exceptional contributions and unwavering commitment to...

Continue Reading
How Bitcoin's Drop Affects Strategy Inc (NASDAQ: MSTR) Investors

Updated Category News Views 137

Understanding the Current Market Landscape As recent market trends demonstrate, Strategy Inc (NASDAQ: MSTR) is seeing significant activity. On one hand, the company is evidently reliant on the performance of Bitcoin. With such dependence, the fluctuations in the value of Bitcoin are crucial to the health of MSTR. This situation poses both risks and opportunities for...

Continue Reading
Significant Attorney Departures to Strengthen Association Law Firm

Updated Category News Views 99

Major Attorney Moves to Association Law Group (ALG) In a noteworthy shift within Florida's community association law landscape, several prominent attorneys have transitioned from Becker & Poliakoff to join the ranks of Association Law Group (ALG). Among them, Michael C. Gongora, Lilliana Farinas-Sabogal, and Adam Cervera are recognized for their extensive experience in...

Continue Reading
EQB's Commitment to Sustainability in Financial Services

Updated Category News Views 175

EQB Focuses on Sustainability in Its Latest Report EQB Inc. (TSX: EQB) has recently published a detailed Responsibility Report, highlighting significant strides towards its sustainability commitments. This annual report encapsulates the company's dedication to fostering an environment of innovation within the Canadian banking sector, with a particular focus on enriching...

Continue Reading
BofA's Downgrade of Sandvik: Navigating Market Pressures Ahead

Updated Category News Views 103

BofA Securities dropped a bomb on Sandvik AB back then by downgrading it from Neutral to Underperform. This move sent shockwaves through the trading floor, mainly because they saw some serious trouble brewing in Sandvik’s Machining and Manufacturing Solutions (SMMS) division. Traders were quick to pick up on the whispers about short cycle pressures that could really...

Continue Reading